Israel Englander’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Israel Englander’s Portfolio DOVA Stock Details DOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-52,187	Closed	-$1.46M	–	4881
2019 Q3	$1.46M	Sell	52,187 -48,752	-48%	-$790K	﹤0.01%	2646
2019 Q2	$1.42M	Buy	+100,939	New	+$960K	﹤0.01%	2605
2018 Q3	–	Sell	-16,765	Closed	-$502K	–	4488
2018 Q2	$502K	Buy	+16,765	New	+$457K	﹤0.01%	3164
2017 Q4	–	Sell	-10,182	Closed	-$247K	–	4244
2017 Q3	$247K	Sell	10,182 -44,183	-81%	-$1.05M	﹤0.01%	3144
2017 Q2	$1.21M	Buy	+54,365	New	+$1.14M	﹤0.01%	2353

Israel Englander's DOVA Position: Q4 2019 in Review

Israel Englander sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 52,187 shares — an estimated $1.46M sold.

Israel Englander first reported a position in DOVA in Q2 2017 and held it in 5 quarters. The position peaked at $1.46M in Q3 2019. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

Israel Englander reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Israel Englander sold 52,187 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $1.46M.
Israel Englander first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q2 2017 and held it in 5 quarters.
Israel Englander's Dova Pharmaceuticals, Inc. Common Stock position peaked at $1.46M in Q3 2019.
0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Millennium Management's 13F filing for Q4 2019, filed 14 Feb 2020.